- Roche Diagnostics growth remains muted amid China headwindsRoche’s Diagnostics division continues to battle growth headwinds, notching a 3% increase in sales.Fierce Biotech · 5d ago↗ source
- Australian biopharma Clinuvel to shed up to 20% of workforce in move to USAustralian biopharma Clinuvel Pharmaceuticals is moving its headquarters to the U.S.— but up to a fifth of the company’s workforce won’t be staying for the trans-Pacific pivot.Fierce Biotech · 5d ago↗ source
- Roche drops TCE for lupus, but hasn’t given up on autoimmune cell therapiesRoche may have scrapped work on a T-cell engager being evaluated for lupus, but the company’s head of pharma told Fierce that still has a strategy for developing cell therapies for autoimmune disea…